Key Highlights

  • 5.14% is the decline in UnitedHealth Group Incorporated (NYSE:UNH) in the November 18, 2026 session, to a traded price of USD 369.87 from a calculated prior close of USD 389.91, a calculated move of USD 20.04.
  • 2.44M shares traded in UnitedHealth Group Incorporated (NYSE:UNH), a calculated 0.27% of 902 million diluted weighted-average shares and calculated dollar Volume of USD 902.5 million, after a 0.65% gap lower at the open.
  • 112.7 billion is the third quarter 2026 Revenue in USD at UnitedHealth Group Incorporated (NYSE:UNH), down 0.4% from USD 113.2 billion, with net Earnings of USD 4.3 billion and adjusted earnings of USD 4.69 per share.
  • 88.4% was the third quarter 2026 medical care ratio at UnitedHealth Group Incorporated (NYSE:UNH), with 2026 outlook for adjusted earnings of at least USD 20.50 per share, a calculated 18.0 times at USD 369.87.

What Drove UnitedHealth Group Incorporated (NYSE:UNH) on High Volume on November 18, 2026 (-USD 20.04, -5.14%)

The traded price of UnitedHealth Group Incorporated (NYSE:UNH) in today's session on November 18, 2026 is USD 369.87, a move of -5.14% on volume of 2.44M shares. On a calculated basis, the prior close was USD 389.91 (USD 369.87 divided by 0.9486) and the USD move is -USD 20.04 (price minus prior close). The stock opened 0.65% below the prior close and traded 4.58% below the open. Using the 902 million diluted weighted-average shares reported for the third quarter, the calculated market Capitalization is about USD 333.62 billion, and the volume equals a calculated 0.27% of those shares.

The Rationale: No Same-Day Catalyst Beyond Margin and Regulatory Overhang for UnitedHealth Group Incorporated (NYSE:UNH)

No catalyst for the November 18, 2026 move was identified in published coverage. The latest results, for the third quarter ended September 30, 2026, were released on October 13, 2026. Revenues were USD 112.7 billion, down about 0.4% from USD 113.2 billion, net earnings were USD 4.3 billion, with USD 4.1 billion attributable to shareholders, GAAP diluted earnings were USD 4.56 per share and adjusted earnings were USD 4.69 per share. The medical care ratio improved to 88.4% from 89.9%. Earlier in 2026, published coverage tied pressure on the shares to Medicare Advantage margin concerns, the risk adjustment transition and a Department of Justice inquiry into Medicare billing.

Valuation, Liquidity and Risks for UnitedHealth Group Incorporated (NYSE:UNH)

The 2026 outlook calls for GAAP diluted earnings of at least USD 19.50 per share and adjusted earnings of at least USD 20.50 per share, which is a calculated 18.0 times at USD 369.87. Cash and short-term investments were USD 28.5 billion at September 30, 2026, against total Debt of about USD 74.3 billion, a calculated net debt of USD 45.8 billion, with a debt-to-capital ratio of 41.7%. Risks include medical cost trends, government program reimbursement and risk adjustment rules, the Justice Department inquiry and leverage.

Where Things Stand

UnitedHealth Group Incorporated (NYSE:UNH) traded at USD 369.87 in today's session on November 18, 2026, down -5.14% from a calculated prior close of USD 389.91, on volume of 2.44M shares. That volume is a calculated 0.27% of 902 million diluted weighted-average shares. No specific catalyst was identified in published coverage. Third quarter 2026 revenues were USD 112.7 billion, the medical care ratio was 88.4%, and adjusted earnings were USD 4.69 per share. Heavy trading in a large capitalization stock can reflect institutional repositioning, and this article is informational and is not Investment advice.